Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to ...
The MARS2 trial put the mesothelioma treatment community off its axis, at least in terms of whether these patients should undergo surgery. The phase III study showed that extended pleurectomy ...
Together, the studies trace an evolution in mesothelioma surgery: from questioning which operation offers the best long-term outcomes to establishing contemporary benchmarks for safety and patient ...
Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to ...
Neoadjuvant and adjuvant capmatinib in resectable non–small cell lung cancer with MET exon 14 skipping mutation or high MET amplification: GEOMETRY-N trial. This is an ASCO Meeting Abstract from the ...
NEW YORK, (February 12, 2026) – A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results